References
- Schlaff WD, Carson SA, Luciano A, Ross D, Berqqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil. Steril.85, 314–325 (2006).
- Buttram VC Jr, Belue JB, Reiter R. Interim report of a study of danazol for the subcutaneous injection of treatment of endometriosis. Fertil. Steril.37, 478–483 (1982).
- Dmowski WP. The role of medical management in the treatment of endometriosis. In: Endometriosis: Advanced Management and Surgical Techniques. Nezhat CR, Berger GS, Nezhat FR, Buttram VC Jr, Nezhat CH (Eds). Springer–Verlag, NY, USA, 229–240 (1995).
- Barbieri RL. Endometriosis and the estrogen threshold theory, relation to surgical and medical treatment. J. Reprod. Med.43, 287–292 (1998).
- Fuldeore MJ, Marx SE, Chwalisz K, Smeeding JE, Brook RA. Add-back therapy use and its impact on LA-persistence in patients with endometriosis. Curr. Med. Res. Opin.26, 729–736 (2010).
- Hurst BS, Gardner SC, Tucker KE, Awoniyi CA, Schlaff WD. Delayed oral estradiol combined with leuprolide increases endometriosis-related pain. JSLS4, 97–101 (2000).
- Freundl G, Godtke K, Gnoth C, Godehardt E, Kienle E. Steroidal ‘add-back’ therapy in patients treated with GnRH agonists. Gynecol. Obstet. Invest.45(Suppl. 1), 22–30 (1998).
- Hornstein MD, Surrey ES, Weisberg GW, Casino LA. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet. Gynecol.91, 16–24 (1998).
- Surrey ES. Surgical and medical management of symptomatic endometriosis: what the evidence shows. Sexuality, Reproduction, Menopause9, S37–S40 (2011).
- Fernandez H, Lucas C, Hedon B, Meyer JL, Mayenga JM, Roux C. One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial. Hum. Reprod.19, 1465–1471 (2004).